General
Cairo Pharmaceuticals (CPCI.CA) - Corporate Governance Report
Published at 24 September 2026 at 07:23Cairo PharmaceuticalsRelated stock:Cairo Pharmaceuticals stockAll Cairo Pharmaceuticals disclosures
Disclosure summary
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Corporate Governance Report for the fiscal year ended on 30/06/2026.
The Corporate Governance Report (2,720 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Corporate Governance Report for the fiscal year ended on 30/06/2026.
The Corporate Governance Report (2,720 KB)